Denali Therapeutics Inc. (DNLI)

NASDAQ: DNLI · Real-Time Price · USD

21.43

+0.12 (0.56%)

At close: Mar 10, 2026, 4:00 PM EDT

21.25

-0.18 (-0.84%)

After-hours: Mar 10, 2026, 7:43 PM EDT

Revenue

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Sep '23 Sep 30, 2023	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
Takeda Collaboration Revenue	-	10.00M	51.92M
Takeda Collaboration Revenue Growth	-	-80.74%	73.51%
Sanofi Collaboration Revenue	-	25.00M	53.40M
Sanofi Collaboration Revenue Growth	-	-53.18%	255.89%
Biogen Collaboration Revenue	295.79M	295.53M	3.15M
Biogen Collaboration Revenue Growth	0.09%	9284.92%	-15.71%
Revenue (Total)	-	330.53M	-

Updated Feb 26, 2026. Data Source: Fiscal.ai.